CD73-IN-4
|
化合物CD73-IN-4
|
2216764-29-1
|
LY3177833
|
CS-2783
|
1627696-51-8
|
Fadraciclib
|
CYC-065
|
1070790-89-4
|
YKL-5-124 TFA
|
|
2748220-93-9
|
Trilaciclib
|
曲拉西利
|
1374743-00-6
|
Trilaciclib hydrochloride
|
曲拉西利双盐酸盐
|
1977495-97-8
|
Cdc7-IN-1
|
CDC7-IN-1 (COMPOUND 13)
|
1402055-25-7
|
MSC2530818
|
MSC2530818
|
1883423-59-3
|
CDK9-IN-8
|
CDK9-IN-8
|
2105956-51-0
|
Enitociclib
|
1610358-56-9
|
1610358-56-9
|
(±)-Enitociclib
|
1610358-53-6
|
1610358-53-6
|
(-)-Enitociclib
|
(-)-BAY-1251152
|
1610358-59-2
|
CLK1-IN-1
|
2123491-32-5
|
2123491-32-5
|
CDK8-IN-1
|
CDK8-IN-1
|
1629633-48-2
|
THZ531
|
THZ531
|
1702809-17-3
|
CK7
|
CDK2/9 INHIBITOR
|
507487-89-0
|
Milciclib
|
PHA-848125
|
802539-81-7
|
Bisindolylmaleimide X hydrochloride
|
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE)
|
145317-11-9
|
CC-671
|
CC-671
|
1618658-88-0
|
PHA-793887
|
3-甲基-N-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-C]吡唑-3-基]丁酰胺
|
718630-59-2
|
INCB 3284
|
INCB-3284
|
887401-92-5
|
AZD2098
|
AZD2098
|
566203-88-1
|
BX471 hydrochloride
|
CS-1298
|
288262-96-4
|
MK-0812 Succinate
|
化合物MK-0812 SUCCINATE
|
851916-42-2
|
BI 639667
|
CCR1 antagonist 8
|
1295298-26-8
|
ALK4290
|
BI-144807
|
1251528-23-0
|
CCR6 antagonist 1
|
CCR6拮抗剂1
|
588674-64-0
|
INCB3344
|
INCB 3344
|
1262238-11-8
|
Mosunetuzumab
|
莫妥珠单抗
|
1905409-39-3
|
Odronextamab
|
奥尼妥单抗
|
1801338-64-6
|
Obinutuzumab
|
阿托珠单抗
|
949142-50-1
|
Ofatumumab
|
奥法木单抗
|
679818-59-8
|
Rituximab
|
利妥昔单抗
|
174722-31-7
|
B7/CD28 interaction inhibitor 1
|
CTLA-4 - INHIBITOR
|
635324-72-0
|
Teplizumab
|
TEPLIZUMAB ( 替利组单抗 )
|
876387-05-2
|
Teclistamab
|
TECLISTAMAB (特立妥单抗 )
|
2119595-80-9
|
CD38 inhibitor 1
|
CD38 inhibitor
|
1700637-55-3
|
MK-0159
|
化合物 MK-0159
|
2641484-61-7
|
PSB-12379
|
PSB-12379
|
1802226-78-3
|
AB-680
|
AB-680
|
2105904-82-1
|
OP-5244
|
|
2381268-71-7
|
CD73-IN-3
|
5-[6-甲基-5-[(1S,2R)-2-丙-2-基环丙基]哒嗪-3-基]-1H-嘧啶-2,4-二酮
|
2375815-63-5
|
Uliledlimab
|
尤莱利单抗
|
2378407-27-1
|
Mupadolimab
|
莫帕利单抗
|
2451856-97-4
|
CDK8-IN-4
|
CDK8-IN-4
|
1613638-82-6
|
AZD4573
|
AZD4573
|
2057509-72-3
|
CDK12-IN-3
|
CDK12-IN-3
|
2220184-50-7
|
Lerociclib dihydrochloride
|
LEROCICLIB HCL ; G1T38 DIHYDROCHLORIDE ; G1T 38 DIHYDROCHLORIDE
|
2097938-59-3
|
PNU112455A hydrochloride
|
N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL
|
21886-12-4
|
CDK12-IN-2
|
化合物CDK12-IN-2
|
2244987-03-7
|
MBQ-167
|
MBQ 167;MBQ167
|
2097938-73-1
|
CDK4/6-IN-2
|
CDK4/6-IN-2
|
1800506-48-2
|
CDK12-IN-E9
|
CDK12 inhibitor E9 S-isomer
|
2020052-55-3
|
NVP-2
|
化合物NVP-2
|
1263373-43-8
|
BRD6989
|
BRD6989
|
642008-81-9
|
DRAK2-IN-1
|
DRAK2-IN-1
|
871837-60-4
|
THZ2
|
THZ2
|
1604810-84-5
|
SRI-29329
|
化合物SRI-29329
|
2086809-58-5
|
CDK5 inhibitor 20-223
|
CDK5 INHIBITOR 20-223
|
865317-30-2
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
Voruciclib
|
VORUCICLIB
|
1000023-04-0
|
hSMG-1 inhibitor 11e
|
化合物T35529
|
1402452-10-1
|
Riviciclib hydrochloride
|
P276-00
|
920113-03-7
|
CDK7/12-IN-1
|
化合物 CDK7/12-IN-1
|
2654075-94-0
|
CDK9-IN-2
|
N2'-(反式-4-氨基环己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-联吡啶]-2',6-二胺
|
1263369-28-3
|
Palbociclib-d8
|
帕博西尼-D8
|
1628752-83-9
|
AT7519
|
4-[(2,6-二氯苄基)氨基]-N-4-哌啶1H-吡唑-3-羧胺
|
844442-38-2
|
AT7519 Hydrochloride
|
N-(4-哌啶基)-4-(2,6-二氯苄氨基)-1H-吡唑-3-羧胺盐酸盐
|
902135-91-5
|
CPS2
|
|
2756741-90-7
|
AZ5576
|
化合物AZ5576
|
2751721-40-9
|
dCeMM2
|
化合物 DCEMM2
|
296771-07-8
|
TNIK-IN-3
|
化合物TNIK-IN-3
|
2754265-25-1
|
Eciruciclib
|
化合物 ECIRUCICLIB
|
1868086-40-1
|
WEE1-IN-5
|
化合物DEBIO-0123
|
2243882-74-6
|
AUZ 454
|
K03861
|
853299-07-7
|
CP681301
|
化合物 CP681301
|
865317-32-4
|
NG 52
|
2-[[6-[(3-氯苯基)氨基]-9-异丙基-9H-嘌呤-2-基]氨基]乙醇
|
212779-48-1
|
XL413 hydrochloride
|
XL413 HYDROCHLORIDE
|
2062200-97-7
|
BMS-265246
|
BMS265246
|
582315-72-8
|
CVT-313
|
CVT 313
|
199986-75-9
|
Senexin A
|
SENEXIN A
|
1366002-50-7
|
Ribociclib hydrochloride
|
7-环戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺盐酸盐
|
1211443-80-9
|
Ribociclib succinate
|
LEE011 琥珀酸盐
|
1374639-75-4
|
Ribociclib succinate hydrate
|
瑞柏司可里布(RIBOCICLIB LEE011)琥珀酸盐水合物
|
1374639-79-8
|
HS38
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide
|
1030203-81-6
|
Abemaciclib methanesulfonate
|
LY2835219
|
1231930-82-7
|
Abemaciclib
|
阿贝西利
|
1231929-97-7
|
6-(Dimethylamino)purine
|
6-二甲基氨基嘌呤
|
938-55-6
|
NCT02
|
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺
|
790245-61-3
|
CDK9-IN-7
|
CDK9-IN-7
|
2369981-71-3
|
Mevociclib
|
SY-1365
|
1816989-16-8
|
Atuveciclib S-Enantiomer
|
Atuveciclib S-Enantiomer
|
250279-81-1
|
PROTAC CDK2/9 Degrader-1
|
|
2408641-24-5
|
BS-181 hydrochloride
|
BS181
|
1397219-81-6
|
CKI-7 free base
|
CKI-7
|
120615-25-0
|
Ipivivint
|
IPIVIVINT
|
1481617-15-5
|
KB-0742 dihydrochloride
|
KB-0742 dihydrochloride
|
2416874-75-2
|
SY-5609
|
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈
|
2417302-07-7
|
BSJ-4-116
|
化合物BSJ-4-116
|
2519823-34-6
|
CDK4/6-IN-6
|
CDK4/6-IN-6
|
2380321-51-5
|